CAS 838816-57-2

Formel: C20H19N3O6S

InChl: InChI=1S/C20H19N3O6S/c1-26-15-8-13(9-16(10-15)27-2)18-22-23-20(29-18)30-11-17(24)21-14-6-4-5-12(7-14)19(25)28-3/h4-10H,11H2,1-3H3,(H,21,24)

InChI Key: MCQJCSNFOKHYLJ-UHFFFAOYSA-N

SMILES: COC1=CC(=CC(=C1)C2=NN=C(O2)SCC(=O)NC3=CC=CC(=C3)C(=O)OC)OC

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

CAS: 838816-57-2

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

Formel: C₂₀H₁₉N₃O₆S

Reinheit: 97%

Molekulargewicht: 429.45

Ref: 54-OR1074273

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

CAS: 838816-57-2

Formel: C₂₀H₁₉N₃O₆S

Reinheit: 97%

Molekulargewicht: 429.4464

Ref: IN-DA01KK1S

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

CAS: 838816-57-2

Reinheit: 97%

Molekulargewicht: 429.45001220703125

Ref: 10-F693157

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

CAS: 838816-57-2

Methyl 3-(2-((5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl)thio)acetamido)benzoate

Formel: C₂₀H₁₉N₃O₆S

Reinheit: 97%

Molekulargewicht: 429.45

Ref: IN-DG01303747

IN04

CAS: 838816-57-2

IN04 is an inhibitor of leucine-rich repeat kinase 1 (LRRK1). It fully hinders the binding of ATP to the human LRRK1 kinase domain, thereby suppressing its kinase activity. IN04 significantly reduces the bone resorption capability of osteoclasts, with an IC₅₀ value of 5.72 μM, and is applicable in osteoporosis research.

Formel: C₂₁H₂₅ClN₂O₃

Molekulargewicht: 388.888

Ref: TM-T213281